Epigenetic mechanisms regulate the prostaglandin e receptor 2 in breast cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 132, Issue 3-5, 2012, Pages 331-338

  To, Sarah Q ^a,b   Takagi, Kiyoshi ^c   Miki, Yasuhiro ^c   Suzuki, Koyu ^d   Abe, Eriko ^d   Yang, Yang ^d   Sasano, Hironobu ^c   Simpson, Evan R ^a,b   Knower, Kevin C ^a   Clyne, Colin D ^a,b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

Author keywords

Aromatase; Breast cancer; DNA methylation; EP2; Epigenetics

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 5 AZA 2' DEOXYCYTIDINE; AROMATASE; AROMATASE INHIBITOR; MESSENGER RNA; PROSTAGLANDIN E RECEPTOR 2; TRICHOSTATIN A;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER THERAPY; CELL STRAIN MCF 7; CONTROLLED STUDY; CORRELATION ANALYSIS; DEACETYLATION; DNA METHYLATION; EPIGENETICS; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN METHYLATION; UPREGULATION;

ADIPOSE TISSUE; AZACITIDINE; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; HYDROXAMIC ACIDS; PROMOTER REGIONS, GENETIC; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; REFERENCE VALUES; STROMAL CELLS;

EID: 84865820582     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2012.07.007     Document Type: Article

References (44)

1. E.R. Simpson, M.S. Mahendroo, G.D. Means, M.W. Kilgore, M.M. Hinshelwood, S. Graham-Lorence, B. Amarneh, Y. Ito, C.R. Fisher, and M.D. Michael Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis Endocrine Reviews 15 3 1994 342 355
2. E.R. Simpson, C. Clyne, G. Rubin, W.C. Boon, K. Robertson, K. Britt, C. Speed, and M. Jones Aromatase - a brief overview Annual Review of Physiology 64 2002 93 127
3. V.R. Agarwal, S.E. Bulun, and E.R. Simpson Quantitative detection of alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in aromatase-expressing human cells by competitive RT-PCR Molecular and Cellular Probes 9 6 1995 453 464
4. N. Harada, T. Utsumi, and Y. Takagi Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis Proceedings of the National Academy of Sciences of the United States of America 90 23 1993 11312 11316
5. S.E. Bulun, and E.R. Simpson Breast cancer and expression of aromatase in breast adipose tissue Trends in Endocrinology and Metabolism 5 3 1994 113 120
6. S.E. Bulun, T.M. Price, J. Aitken, M.S. Mahendroo, and E.R. Simpson A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription Journal of Clinical Endocrinology and Metabolism 77 6 1993 1622 1628
7. S.E. Bulun, and E.R. Simpson Regulation of aromatase expression in human tissues Breast Cancer Research and Treatment 30 1 1994 19 29
8. I. Czajka-Oraniec, and E.R. Simpson Aromatase research and its clinical significance Endokrynologia Polska 61 1 2010 126 134
9. J.W. Regan EP2 and EP4 prostanoid receptor signaling Life Sciences 74 2-3 2003 143 153
10. Y. Zhao, V.R. Agarwal, C.R. Mendelson, and E.R. Simpson Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene Endocrinology 137 12 1996 5739 5742
11. Y. Zhao, V.R. Agarwal, C.R. Mendelson, and E.R. Simpson Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture Journal of Steroid Biochemistry and Molecular Biology 61 3-6 1997 203 210
12. Y. Zhao, J.E. Nichols, S.E. Bulun, C.R. Mendelson, and E.R. Simpson Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter Journal of Biological Chemistry 270 27 1995 16449 16457
13. V.R. Agarwal, S.E. Bulun, M. Leitch, R. Rohrich, and E.R. Simpson Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients Journal of Clinical Endocrinology and Metabolism 81 11 1996 3843 3849
14. K. Subbaramaiah, C. Hudis, S.H. Chang, T. Hla, and A.J. Dannenberg EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange Journal of Biological Chemistry 283 6 2008 3433 3444
15. T. Heinzel, R.M. Lavinsky, T.M. Mullen, M. Soderstrom, C.D. Laherty, J. Torchia, W.M. Yang, G. Brard, S.D. Ngo, J.R. Davie, E. Seto, R.N. Eisenman, D.W. Rose, C.K. Glass, and M.G. Rosenfeld A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression Nature 387 6628 1997 43 48
16. W. Doerfler, B. Weisshaar, A. Hoeveler, D. Knebel, U. Muller, P. Dobrzanski, U. Lichtenberg, S. Achten, and R. Hermann Promoter inhibition by DNA methylation: a reversible signal Gene 74 1 1988 129 133
17. M. Izawa, T. Harada, F. Taniguchi, Y. Ohama, Y. Takenaka, and N. Terakawa An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells Fertility and Sterility 2007
18. L.O. Dannenberg, and H.J. Edenberg Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation BMC Genomics 7 2006 181
19. M. Leshin 5-Azacytidine and sodium butyrate induce expression of aromatase in fibroblasts from chickens carrying the henny feathering trait but not from wild-type chickens Proceedings of the National Academy of Sciences of the United States of America 82 9 1985 3005 3009
20. R. Furbass, H.M. Said, M. Schwerin, and J. Vanselow Chromatin structure of the bovine Cyp19 promoter 1.1. DNaseI hypersensitive sites and DNA hypomethylation correlate with placental expression European Journal of Biochemistry 268 5 2001 1222 1227
21. R. Furbass, R. Selimyan, and J. Vanselow DNA methylation and chromatin accessibility of the proximal Cyp19 promoter region 1.5/2 correlate with expression levels in sheep placentomes Molecular Reproduction and Development 75 1 2008 1 7
22. J. Vanselow, R. Pohland, and R. Furbass Promoter-2-derived Cyp19 expression in bovine granulosa cells coincides with gene-specific DNA hypo-methylation Molecular and Cellular Endocrinology 233 1-2 2005 57 64
23. J. Vanselow, R. Selimyan, and R. Furbass DNA methylation of placenta-specific Cyp19 promoters of cattle and sheep Experimental and Clinical Endocrinology and Diabetes 116 7 2008 437 442
24. M. Demura, and S.E. Bulun CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity Molecular and Cellular Endocrinology 283 1-2 2008 127 132
25. K.C. Knower, S.Q. To, E.R. Simpson, and C.D. Clyne Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts Molecular and Cellular Endocrinology 321 2 2010 123 130
26. L. Tian, M. Suzuki, T. Nakajima, R. Kubo, Y. Sekine, K. Shibuya, K. Hiroshima, Y. Nakatani, T. Fujisawa, and I. Yoshino Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation Cancer 113 6 2008 1396 1403
27. Y. Sugino, A. Misawa, J. Inoue, M. Kitagawa, H. Hosoi, T. Sugimoto, I. Imoto, and J. Inazawa Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas Oncogene 26 53 2007 7401 7413
28. G.E. Ackerman, M.E. Smith, C.R. Mendelson, P.C. MacDonald, and E.R. Simpson Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture Journal of Clinical Endocrinology and Metabolism 53 2 1981 412 417
29. Y. Miki, T. Suzuki, C. Tazawa, Y. Yamaguchi, K. Kitada, S. Honma, T. Moriya, H. Hirakawa, D.B. Evans, S. Hayashi, N. Ohuchi, and H. Sasano Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells Cancer Research 67 8 2007 3945 3954
30. C. Rohde, Y. Zhang, R. Reinhardt, and A. Jeltsch BISMA - fast and accurate bisulfite sequencing data analysis of individual clones from unique and repetitive sequences BMC Bioinformatics 11 2010 230
31. S.K. Huang, A.S. Fisher, A.M. Scruggs, E.S. White, C.M. Hogaboam, B.C. Richardson, and M. Peters-Golden Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice American Journal of Pathology 177 5 2010 2245 2255
32. S.G. Gray, N. Al-Sarraf, A.M. Baird, M.C. Cathcart, E. McGovern, and K.J. O'Byrne Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications European Journal of Cancer 45 17 2009 3087 3097
33. I. Wolf, S. Bose, J.C. Desmond, B.T. Lin, E.A. Williamson, B.Y. Karlan, and H.P. Koeffler Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer Breast Cancer Research and Treatment 105 2 2007 139 155
34. M.A. Thorat, A. Morimiya, S. Mehrotra, R. Konger, and S.S. Badve Prostanoid receptor EP1 expression in breast cancer Modern Pathology 21 1 2008 15 21
35. J.A. Richards, and R.W. Brueggemeier Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes Journal of Clinical Endocrinology and Metabolism 88 6 2003 2810 2816
36. G.S. Watts, B.W. Futscher, N. Holtan, K. Degeest, F.E. Domann, and S.L. Rose DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage BMC Medical Genomics 1 2008 47
37. F. Graziano, F. Arduini, A. Ruzzo, I. Bearzi, B. Humar, H. More, R. Silva, P. Muretto, P. Guilford, E. Testa, D. Mari, M. Magnani, and S. Cascinu Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer Clinical Cancer Research 10 8 2004 2784 2789
38. J. Roman-Gomez, A. Jimenez-Velasco, J.A. Castillejo, X. Agirre, M. Barrios, G. Navarro, F.J. Molina, M.J. Calasanz, F. Prosper, A. Heiniger, and A. Torres Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia Blood 104 8 2004 2492 2498
39. M.V. Brock, M. Gou, Y. Akiyama, A. Muller, T.T. Wu, E. Montgomery, M. Deasel, P. Germonpre, L. Rubinson, R.F. Heitmiller, S.C. Yang, A.A. Forastiere, S.B. Baylin, and J.G. Herman Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma Clinical Cancer Research 9 8 2003 2912 2919
40. P.W. Laird Cancer epigenetics Human Molecular Genetics 14 Spec No. 1 2005 R65 R76
41. J. Mehrotra, M. Vali, M. McVeigh, S.L. Kominsky, M.J. Fackler, J. Lahti-Domenici, K. Polyak, N. Sacchi, E. Garrett-Mayer, P. Argani, and S. Sukumar Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung Clinical Cancer Research 10 9 2004 3104 3109
42. P. Robbins, S. Pinder, N. de Klerk, H. Dawkins, J. Harvey, G. Sterrett, I. Ellis, and C. Elston Histological grading of breast carcinomas: a study of interobserver agreement Human Pathology 26 8 1995 873 879
43. D.C. Allred, J.M. Harvey, M. Berardo, and G.M. Clark Prognostic and predictive factors in breast cancer by immunohistochemical analysis Modern Pathology 11 2 1998 155 168
44. A.C. Wolff, M.E. Hammond, J.N. Schwartz, K.L. Hagerty, D.C. Allred, R.J. Cote, M. Dowsett, P.L. Fitzgibbons, W.M. Hanna, A. Langer, L.M. McShane, S. Paik, M.D. Pegram, E.A. Perez, M.F. Press, A. Rhodes, C. Sturgeon, S.E. Taube, R. Tubbs, G.H. Vance, M. van de Vijver, T.M. Wheeler, and D.F. Hayes American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer Archives of Pathology and Laboratory Medicine 131 1 2007 18 43